Viking Global Investors LP

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

93

Stocks Covered

35

Latest Filing

Nov 14, 2024

Filings

TRVI

Trevi Therapeutics, Inc.

SC 13G/A · Feb 14, 2023

10.0%

6.2M shares

INBX

Inhibrx, Inc.

SC 13G/A · Feb 14, 2023

15.2%

6.6M shares

FIGS

FIGS, Inc.

SC 13G/A · Feb 14, 2023

0.0%

0 shares

APG

APi Group Corporation

SC 13G/A · Feb 14, 2023

17.4%

42.1M shares

LAB

Standard BioTools Inc.

SC 13G/A · Feb 14, 2023

9.5%

8.3M shares

DNA

Ginkgo Bioworks Holdings, Inc.

SC 13G/A · Feb 14, 2023

9.4%

143.1M shares

COUP

COUPA SOFTWARE INCORPORATED

SC 13G/A · Feb 14, 2023

0.0%

0 shares

PEPG

PepGen Inc.

SC 13G/A · Feb 14, 2023

6.5%

1.5M shares

CLDX

Celldex Therapeutics, Inc.

SC 13G/A · Feb 14, 2023

0.0%

0 shares

PRCT

PROCEPT BioRobotics Corporation

SC 13G/A · Feb 14, 2023

0.0%

0 shares

EWTX

Edgewise Therapeutics, Inc.

SC 13G/A · Feb 14, 2023

7.0%

4.4M shares

OHPA

Orion Acquisition Corp.

SC 13G/A · Feb 14, 2023

0.0%

0 shares

N/A

Frazier Lifesciences Acquisition Corporation

SC 13D/A · Nov 25, 2022

0.0%

0 shares

N/A

Frazier Lifesciences Acquisition Corporation

SC 13D · Nov 3, 2022

25.7%

3.7M shares

N/A

* Frazier Lifesciences Acquisitions Corporation

SC 13G · Nov 2, 2022

19.8%

2.8M shares

TRVI

* Trevi Therapeutics, Inc.

SC 13G · Oct 7, 2022

10.0%

6.0M shares

AMLX

INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d- 1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* Amylyx Pharmaceuticals, Inc.

SC 13G/A · Sep 10, 2022

9.9%

5.8M shares

DNA

* Ginkgo Bioworks Holdings, Inc.

SC 13G · Jul 1, 2022

9.7%

115.1M shares

CLDX

* Celldex Therapeutics, Inc.

SC 13G · Jun 10, 2022

5.1%

2.4M shares

PEPG

* PepGen Inc.

SC 13G · May 20, 2022

8.0%

1.8M shares

LAB

* Standard BioTools Inc.

SC 13G · Apr 14, 2022

9.5%

8.1M shares

PRCT

* PROCEPT BioRobotics Corporation

SC 13G/A · Mar 22, 2022

8.4%

3.7M shares

N/A

Nuance Communications, Inc.

SC 13G/A · Feb 14, 2022

0.0%

0 shares

FIGS

* FIGS, Inc.

SC 13G/A · Feb 14, 2022

8.8%

13.3M shares

OHPA

* Orion Acquisition Corp.

SC 13G/A · Feb 14, 2022

8.9%

3.7M shares

FDMT

4D Molecular Therapeutics, Inc.

SC 13G/A · Feb 14, 2022

12.3%

3.9M shares

ADPT

Adaptive Biotechnologies Corporation

SC 13G/A · Feb 14, 2022

21.3%

30.0M shares

ATHA

Athira Pharma, Inc.

SC 13G/A · Feb 14, 2022

0.0%

0 shares

INBX

* Inhibrix, Inc.

SC 13G/A · Feb 14, 2022

14.0%

5.3M shares

EWTX

* Edgewise Therapeutics, Inc.

SC 13G/A · Feb 14, 2022

5.5%

2.7M shares

N/A

SC 13G/A 1 brhc10033275_sc13ga.htm SC 13GA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934* (Amendment 1*) MUDRICK CAPITAL ACQUISITION CORPORATION II

SC 13G/A · Feb 14, 2022

0.0%

0 shares

PHVS

* Pharvaris N.V.

SC 13G/A · Feb 14, 2022

7.4%

2.5M shares

PMVP

PMV Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2022

3.9%

1.8M shares

PRCT

* PROCEPT BioRobotics Corporation

SC 13G/A · Feb 14, 2022

11.3%

4.9M shares

RLYB

* Rallybio Corporation

SC 13G/A · Feb 14, 2022

13.1%

4.2M shares

ROIV

* Roivant Sciences Ltd.

SC 13G · Feb 14, 2022

12.8%

0 shares

TALS

* Talaris Therapeutics, Inc.

SC 13G/A · Feb 14, 2022

8.0%

3.3M shares

ZNTL

Zentalis Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2022

4.7%

2.1M shares

ABCL

* AbCellera Biologics Inc.

SC 13G/A · Feb 14, 2022

0.0%

0 shares

COUP

* COUPA SOFTWARE INCORPORATED

SC 13G/A · Feb 14, 2022

5.6%

4.2M shares

AMLX

* Amylyx Pharmaceuticals, Inc.

SC 13G · Jan 21, 2022

12.4%

7.2M shares

GH

* Guardant Health, Inc.

SC 13G · Jan 18, 2022

5.0%

5.1M shares

APG

APi Group Corporation

SC 13G/A · Jan 5, 2022

17.3%

41.5M shares